IP Verse

Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) - EP3536712

PATENT ANALYSIS

Patent Details

Grant Date
May 31, 2023
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

AMGEN INC.

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you